Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 10

LAMPIRAN 1: Jadwal Penelitian

LAMPIRAN 2: Hasil Penelitian


NO

INISIAL

USIA

FI

28

JENIS
KELAMI
N
L

DA

23

DT

21

DS

29

DP

36

AZ

35

7
8

AH
DA

55
36

L
P

AMP

28

10

AW

33

11

EG

28

12

IBM

49

13

ISP

36

14
15

GB
KJ

58
32

P
L

16
17

IJ
MLN

35
20

L
L

18

HB

36

19

HT

27

20

FL

45

KOMBINASI
ARV
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P
TDF+3TC+NVP
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+EFV
AZT+3TC+NV
P
AZT+3TC+EFV
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P

KADA
R
SGPT
28
24
276
15
40
83
81
123
41
26
43
31
37
20
13
20
30
22
11
42

21

JT

29

22

MP

29

23

MN

31

24

LBU

29

25

IS

32

26

LA

30

27

RT

29

28

MBH

44

29

RS

25

30

MW

39

31

RM

34

32
33

RS
SS

28
28

L
P

34

NBMN

50

35

NG

33

36

NBN

30

37
38

MH
RBA

43
58

L
P

39

SH

21

40
41

RPS
SBH

33
49

L
P

42

RS

34

43

YAE

41

AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+EFV
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P
TDF+3TC+NVP
AZT+3TC+NV
P
AZT+3TC+NV
P
TDF+3TC+NVP
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV

41
10
14
19
15
33
15
29
69
665
31
30
25
34
11
346
14
109
284
42
34
32
27

44

YT

26

45

TW

28

46

TDM

31

47

YBL

52

48
49

SBS
YBM

30
22

P
P

50

SK

31

P
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P
AZT+3TC+NV
P
TDF+3TC+NVP
AZT+3TC+NV
P
AZT+3TC+NV
P

27
13
15
26
18
15
12

LAMPIRAN 3: Analisis SPSS


Frequency Table
USIA
Valid
Frequency Percent Percent
Valid

Cumulative
Percent

REMAJA AKHIR
(17- 25 TAHUN)

12.0

12.0

12.0

DEWASA AWAL
(26 - 35 TAHUN)

27

54.0

54.0

66.0

DEWASA AKHIR
(36 - 45 TAHUN)

10

20.0

20.0

86.0

LANSIA AWAL
(46 - 55 TAHUN)

10.0

10.0

96.0

LANSIA AKHIR
(56- 65)

4.0

4.0

100.0

50

100.0

100.0

Total

JENIS KELAMIN
Valid
Frequency Percent Percent
Valid LAKI-LAKI

Cumulative
Percent

28

56.0

56.0

56.0

PEREMPUAN

22

44.0

44.0

100.0

Total

50

100.0

100.0

JENIS ARV
Valid Cumulative
Frequency Percent Percent
Percent
Valid AZT + 3TC + NVP

43

86.0

86.0

86.0

AZT + 3TC + EFV

6.0

6.0

92.0

TDF + 3TC + NVP

8.0

8.0

100.0

50

100.0

100.0

Total

KADAR SGPT
Valid Cumulative
Frequency Percent Percent
Percent
Valid NORMAL

41

82.0

82.0

82.0

DERAJAT 1

6.0

6.0

88.0

DERAJAT 2

4.0

4.0

92.0

DERAJAT 3

6.0

6.0

98.0

DERAJAT 4

2.0

2.0

100.0

50

100.0

100.0

Total
Crosstabs

JENIS KELAMIN * KADAR SGPT Crosstabulation


KADAR SGPT
MENINGKAT NORMAL
LAKI-LAKI

JENIS

Count
% within KADAR SGPT

KELAMIN

7
77.8%

PEREMPUAN Count
% within KADAR SGPT
Total

22.2%

20

22

48.8% 44.0%

9
100.0%

28

51.2% 56.0%

Count
% within KADAR SGPT

21

Total

41

50

100.0% 100.0%

USIA * KADAR SGPT Crosstabulation


KADAR SGPT
MENINGKAT NORMAL
USIA

Total

REMAJA AKHIR
(17- 25 TAHUN)

Count

DEWASA AWAL
(26 - 35 TAHUN)

Count

Total

33.3%

7.3%

12.0%

26

27

% within KADAR SGPT

11.1%

63.4%

54.0%

DEWASA AKHIR Count


(36 - 45 TAHUN) % within KADAR SGPT

10

33.3%

17.1%

20.0%

11.1%

9.8%

10.0%

11.1%

2.4%

4.0%

41

50

% within KADAR SGPT

LANSIA AWAL
(46 - 55 TAHUN)

Count

LANSIA AKHIR
(56- 65)

Count

% within KADAR SGPT


% within KADAR SGPT
Count
% within KADAR SGPT

100.0%

100.0% 100.0%

ARV*KADAR SGPT
KADAR SGPT
MENINGKAT NORMAL
ARV

NEVIRAPINE Count
% within KADAR SGPT
EFAVIRENZ Count
% within KADAR SGPT

Total

Count
% within KADAR SGPT

Total

38

47

100.0%

92.7%

94.0%

.0%

7.3%

6.0%

41

50

100.0%

100.0%

100.0%

Exact Sig.
(2-sided)

Exact Sig.
(1-sided)

Chi-Square Tests
Value
Pearson Chi-Square
Continuity Correctionb
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Casesb

Asymp. Sig.
(2-sided)

df

.701a
.004
1.232

1
1
1

.403
.951
.267
1.000

.687

.544

.407

50

a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is .54.
b. Computed only for a 2x2 table

LAMPIRAN 4: Surat Permohonan Izin Penelitian dan Pengambilan Data

LAMPIRAN 5: Surat Persetujuan Izin Penelitian

You might also like